Sanofi Consumer Healthcare India Ltd – Q1 CY26 Results

key financial highlights

• Revenue from Operations:
  • Revenue (Q4 FY26): ₹2,292 Million
    • QoQ Change: -8.7%
    • YoY Change: +32.8%
  • Previous Quarter (Q3 FY26): ₹2,510 Million
  • Previous Year (Q4 FY25): ₹1,726 Million
• Profit After Tax (PAT):
  • PAT (Q4 FY26): ₹678 Million
    • QoQ Change: +2.0%
    • YoY Change: +35.6%
  • Previous Quarter (Q3 FY26): ₹665 Million
  • Previous Year (Q4 FY25): ₹500 Million
• QoQ Performance
  • Revenue Trend: Decline
  • Profit Trend: Stable growth

Margin Analysis

Key Drivers:

• Expense growth lower than revenue growth YoY
• Sequential expense decline supported margins
• Strong operating efficiency

Derived Margins:

• Net Profit Margin: ~29.6% (very strong for FMCG/healthcare)

Key Signal: This is a high-margin business with strong pricing power and brand strength

Earning quality check

Drivers:

• No exceptional items in the quarter
• Strong core operating profit (₹907 Mn PBT)
• Limited dependence on other income

Interpretation:

• Earnings are high quality and sustainable, driven by core business

balance sheet Analysis

• Equity Share Capital: ₹230 Mn
• Other Equity: ₹3,610 Mn

Insight:

• Strong net worth base
• Asset-light consumer healthcare model
• Low leverage profile (inferred)

key risks

• Seasonal demand fluctuations (healthcare products)
• Regulatory pricing controls (OTC/pharma overlap)
• Competitive FMCG/OTC landscape
• Dependence on key brands

management strategy signals

Focus Area:

• Brand-led growth
• Cost efficiency
• Premium product positioning
• Expansion in consumer healthcare portfolio

Financial Metrics

Quarterly Performance Context